Isabel Pajares

Ancestry-Shift Refinement Mapping of the C6orf97-ESR1 Breast Cancer Susceptibility Locus

Simon Stacey, Patrick Sulem, Carlo Zanon et al. · PLoS Genetics · 2010 · 106 citations · Full text

Comparative safety of BRAF and MEK inhibitors (vemurafenib, dabrafenib and trametinib) in first-line therapy for BRAF-mutated metastatic melanoma

Ana Cebollero, Teresa Puértolas, Isabel Pajares et al. · Molecular and Clinical Oncology · 2016 · 27 citations · Full text

Pathology, Pharmacotherapy, Dermatology +16

Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC)

Raquel Andrés, Isabel Pajares, Judith Balmañà et al. · Clinical & Translational Oncology · 2013 · 25 citations

Breast Oncology, Cancer Pathology, Tumor Heterogeneity +10

Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib

César Serrano, Xavier García del Muro, Claudia Valverde et al. · The Oncologist · 2018 · 12 citations · Full text